Top

Reactions Weekly

Published in:

01-10-2022 | Prostate Cancer | Case report

Apalutamide

Acute generalised exanthematous pustulosis and skin rash: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kato T, et al. Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. International Journal of Clinical Oncology 27: 1348-1355, No. 8, 2022. Available from: URL: https://link.springer.de/link/service/journals/10147/index.htm

Title: Apalutamide
Acute generalised exanthematous pustulosis and skin rash: 2 case reports
Publication date: 01-10-2022
Publisher: Springer International Publishing
Keywords: Prostate Cancer
Prostate Cancer
Apalutamide
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-24365-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Apalutamide

Acute generalised exanthematous pustulosis and skin rash: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Amphotericin-B

Measles-mumps-and-rubella-virus-vaccine

Metformin

Chlorothiazide

Flecainide

Sevoflurane